We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£520.00
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 3 months
US Anti-Rejection Drugs & Immunosuppressants Liver Study
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 88 days · 88 data points
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 88 days • 1 price levels
Price Analysis
Most common price: £520 (88 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 88 days
Description
Key Features
Provides a detailed outlook for anti-rejection drugs and immunosuppressants for liver diseases in the United States from 2023 to 2028.
Includes latent demand estimates, also known as potential industry earnings (P.I.E.), measured in millions of U.S. dollars.
Covers data across approximately 12,600 cities to provide a wide-reaching geographical analysis of the United States.
Offers comparative benchmarks by reporting the percent share each city holds of its state and the entire country.
Supports distribution and market analysis through a statistical approach to city-level demand.
Product Specifications
- Format
- paperback
- ASIN
- B0BLR565L7
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 09 November 2022
Similar Products You Might Like
The 2023-2028 Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments in Japan
Anti-Rejection Drugs and Immunosuppressants Liver Study
World Outlook: Anti-Rejection Drugs for Liver Diseases
Price unavailable
The 2021-2026 World Outlook for Liver Disease Treatments
India Liver Cirrhosis Drugs Market Outlook 2023-2028 Study
The 2023-2028 Outlook for Liver Health Supplements in India
The 2023-2028 Outlook for Liver Health Supplements in the United States
World Outlook for Liver Disease Treatments 2025-2030
Price unavailable
The 2023-2028 Outlook for Liver Health Supplements in Japan
The 2023-2028 Outlook for Liver Health Supplements in China
The 2023-2028 Outlook for Liver Cirrhosis Drugs in China
US Liver Cancer Drug Outlook 2016-2021 Econometric Study
The 2025-2030 World Outlook for Liver Cirrhosis Drugs
Price unavailable
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
The 2023-2028 Outlook for Liver Health Supplements for US Zip Codes
Targeted Therapy Liver Cancer Drugs Outlook 2023-2028
US Liver Cirrhosis Drug Market Outlook 2023-2028 Report
Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028
The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City
Liver Physiology and Treatment of Liver Diseases
Allied Health Press
Chronic Liver Disease: From Molecular Biology to Therapy (Hepatology Research and Clinical Developments)
Liver Diseases: A Multidisciplinary Textbook
Springer
World Outlook: Targeted Therapy Liver Cancer Drugs 2025-2030
